Chronic Subdural Medical Management

Neurosurg Clin N Am. 2017 Apr;28(2):211-217. doi: 10.1016/j.nec.2016.11.003. Epub 2017 Feb 1.

Abstract

Chronic subdural hematomas (cSDHs) that are asymptomatic or have minimal symptoms have become more prevalent, with an increased rate of detection with neuroimaging in the setting of an aging population and increasing use of anticoagulants. These cSDHs have been known to spontaneously resolve, and subsequent efforts have been made to study the role of nonoperative initial medical management strategies in these patients. Current and potential strategies for the medical management of cSDH are discussed.

Keywords: Angiotensin-converting enzyme inhibitor; Antiepileptic drug; Antifibrinolytic; HMG-CoA reductase inhibitor; Medical management; Nonoperative; Steroid; Subdural hematoma.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antifibrinolytic Agents / therapeutic use
  • Hematoma, Subdural, Chronic / complications
  • Hematoma, Subdural, Chronic / diagnosis
  • Hematoma, Subdural, Chronic / therapy*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Inflammation / complications
  • Inflammation / prevention & control
  • Seizures / complications
  • Seizures / prevention & control
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Angiotensin-Converting Enzyme Inhibitors
  • Antifibrinolytic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors